ENDPOINTS

FDA leadership preps for summer biopharma listening tou...

FDA Commissioner Marty Makary, newly minted CBER chief Vinay Prasad and Principa...

Boundless Bio changes plans for cancer drug after toxic...

Boundless Bio has hit the reset button in the face of toxicity issues, nixing on...

FDA rejects Savara’s rare lung disease drug over limite...

The FDA has rejected Savara’s application for its rare lung disease candidate ov...

Sernova chair resigns following insider trading charges...

Canadian cell therapy biotech Sernova said Sunday that its board chairman Ross H...

Boundless changes plans for cancer drug after toxicity ...

Boundless Bio has hit the reset button in the face of toxicity issues, nixing on...

Updated: Patient dies in Rocket gene therapy trial, whi...

Rocket Pharmaceuticals said Tuesday morning that a patient in its gene therapy t...

RFK Jr. ends routine Covid vaccine guidance for kids, p...

The CDC will no longer recommend routine Covid-19 vaccines for healthy kids and ...

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

Eli Lilly is deepening its presence in the non-opioid pain field by buying Calif...

FDA approves Liquidia's inhaled hypertension drug in tw...

The FDA approved Liquidia’s treprostinil program for two related kinds of high b...

ITM reveals up to $262M debt financing; Caris Life Scie...

Plus, news about Lexeo, TreeFrog Therapeutics, Hansa Biopharma, AbbVie, Elpiscie...

Gilgamesh’s psychedelic shows rapid effect in depressio...

Gilgamesh’s drug showed swift and durable effects as a treatment for major depre...

Exclusive: Brooklyn Health raises $6.5M to standardize ...

Trials for mental health drugs sometimes fail not because the medicine does not ...

Biogen taps City Therapeutics in RNAi deal worth up to $1B

Biogen is diving into the RNAi field with City Therapeutics, a biotech led by se...

Exclusive: Brooklyn Health raises $6.5M to standardize ...

Trials for mental health drugs sometimes fail not because the medicine does not ...

Blackstone's GRIN inks epilepsy licensing deal with Ang...

Italian drugmaker Angelini Pharma is set to help GRIN Therapeutics take its neur...

Patient dies in Rocket gene therapy trial, on clinical ...

Rocket Pharmaceuticals said Tuesday morning that a patient in its gene therapy t...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.